CYTK
Cytokinetics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$60.06
+0.06 ▲ +0.10%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$60.06
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -6.53 | Insider Own | 2.27% | Shs Outstand | 0.12B | Perf Week | -0.58% |
| Market Cap | 7.40B | Forward P/E | - | EPS next Y | 28.2% | Insider Trans | -8.37% | Shs Float | 0.12B | Perf Month | -10.09% |
| Enterprise Value | 7.80B | PEG | - | EPS next Q | -1.65 | Inst Own | 111.7% | Short Float | 12.77% | Perf Quarter | -0.42% |
| Income | -0.78B | P/S | 84.02 | EPS this Y | 2.27% | Inst Trans | -2.84% | Short Ratio | 7.85 | Perf Half Y | 12.64% |
| Sales | 0.09B | P/B | - | EPS next 5Y | 27.63% | ROA | -55.55% | Short Interest | 15.37M | Perf YTD | -5.48% |
| Book/sh | -5.37 | P/C | 8.36 | EPS past 3/5Y | -14.71% -27.07% | ROE | - | 52W High | -15.38% ($70.98) | Perf Year | 35.27% |
| Cash/sh | 7.19 | P/FCF | - | Sales past 3/5Y | -2.36% 9.54% | ROIC | -139.1% | 52W Low | 104.91% ($29.31) | Perf 3Y | 61.15% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -23.8% | Gross Margin | 88.5% | Volatility(W/M) | 5.27% 4.18% | Perf 5Y | 163.19% |
| Dividend TTM | - | EV/Sales | 88.55 | Sales Y/Y TTM | 376.56% | Oper. Margin | -695.44% | ATR (14) | 2.85 | Perf 10Y | 844.34% |
| Dividend Ex-Date | - | Quick Ratio | 4.53 | EPS Q/Q | -17.65% | Profit Margin | -891.6% | RSI (14) | 41.22 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.53 | Sales Q/Q | 4.89% | SMA20 | -6.09% ($63.95) | Beta | 0.53 | Target Price | $91.61 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -5.93% ($63.85) | Rel Volume | 0.99 | Prev Close | $60 |
| Employees | 673 | LT Debt/Eq | - | EPS/Sales Surpr. | 4.12% 156.35% | SMA200 | 14.42% ($52.49) | Avg Volume(3M) | 1.96M | Price | $60.06 |
| IPO | 2004/4/29 | Option/Short | Yes/Yes | Trades | 20140 | Volume | 1,933,991 | Change | 0.1% |
뉴스 로딩 중...